JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2026. Vol. 71. № 1
DOI:10.33266/1024-6177-2026-71-1-39-41
Yu.A. Kaidash1, E.L.Shaidiyarova 1, I.A. Baryshnikov1, P.V. Sychev1,
E.V. Mayakova1, A.V. Belostotsky1, Yu.D. Udalov 2
First Experience in Treatment of Papillary Thyroid Cancer
with Metastatic Lung Infection in a 12-year-old Patient (Clinical Case)
1 Federal Scientific Clinical Center for Medical Radiology and Oncology, Dimitrovgrad, Russia
2 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: Yulia Aleksandrovna Kaidash, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To demonstrate the successful experience of using systemic radioiodine therapy in the treatment of thyroid cancer in children.
Material and methods: In the FSBI FSCCRO of FMBA of Russia, as part of the implementation of the State assignment of FMBA of Russia, the development of a modern tool for epidemiological analysis of the results of the use of 131I radionuclide therapy in the treatment of thyroid cancer in the system of FMBA of Russia is carried out. Over 2.5 years of studies, data on the carrying out of radioiodine therapy for thyroid cancer in the nuclear medicine centers of the FMBA institutions of Russia have been studied on more than 1500 patients from different parts of the Russian Federation. The necessary medical documentation and clinical and anamnestic data of patients who underwent radioiodine therapy have been studied, and information has been collected and analyzed epidemiologically, and entered into an electronic database of patients of different age groups. However, in our database clinical cases of children’s treatment are quite rare.
Results: Due to the lack of an evidence based on prospective and retrospective studies with a large sample of pediatric patients, a significant portion of the treatment concepts for differentiated thyroid cancer in children are derived from the experience of treating adult patients. However, the more aggressive course of the disease in children, coupled with a good overall prognosis and a long life expectancy, during which adverse effects of radioiodine therapy may occur, requires a personalized approach, as demonstrated in our clinical case.
Conclusion: Based on the above, it is evident that it is necessary to develop special recommendations for the treatment and monitoring of pediatric patients with thyroid neoplasms.
Keywords: thyroid cancer, childhood, radioiodine therapy, 131I
For citation: Kaidash YuA, Shaidiyarova EL, Baryshnikov IA, Sychev PV, Mayakova EV, Belostotsky AV, Udalov YuD. The first experience of papillary thyroid cancer treatment with metastatic lung lesions in a 12-year-old patient (Clinical Case). Medical Radiology and Radiation Safety. 2026;71(1):39–41. (In Russian). DOI:10.33266/1024-6177-2026-71-1-39-41
References
1. Differentsirovannyy Rak Shchitovidnoy Zhelezy = Differentiated Thyroid Cancer. Clinical Guidelines. Moscow, Ministry of Health of the Russian Federation Publ., 2020. 56 p. (In Russ.).
2. Durnov L.A., Goldobenko G.V. Detskaya Onkologiya = Pediatric Oncology. Textbook. Moscow, Meditsina Publ., 2002. 607 p. (In Russ.).
3. Paches A.I. Opukholi Golovy i Shei = Head and Neck Tumors. Clinical Guidelines. Moscow, Prakticheskaya Meditsina Publ., 2013. P. 454-473 (In Russ.).
4. Detskaya Onkologiya = Pediatric Oncology. National Guidelines. Ed. Aliyev M.D., Polyakov V.G., Mentkevich G.L., Mayakova S.A. Moscow, Prakticheskaya Meditsina Publ., 2012. 684 (In Russ.).
5. Rumyantsev P.O., Il’in A.A., Rumyantseva U.V., Sayenko V.A. Rak Shchitovidnoy Zhelezy. Sovremennyye Podkhody k Diagnostike i Lecheniyu = Thyroid Cancer. Modern Approaches to Diagnostics and Treatment. Moscow, GEOTAR-Media Publ., 2009. 448 p. (In Russ.).
6. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Sherman S.I., Tuttle R.M. American Thyroid Association Guidelines Taskforce: Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2006 Feb;16;2:109-42. Doi: 10.1089/thy.2006.16.109. PMID: 16420177.
7. Mhiri A., Elbez I., Slim I., Ben Slimène M.F. Differentiated Thyroid Cancer in Children: The Contribution of Radioiodine Therapy. Thyroid Disorders Ther. 2015;4:171. Doi: 10.4172/2167-7948.1000171.
8. Sychev P.V., Udalov Yu.D., Mayakova Ye.V., Shcherbakov M.I., Kaydash Yu.A., Kadyrova A.M. RADIOR-25. Certificate of State Registration of the Database No. 2024625254 Russian Federation. No. 2024625013. Declared 07.11.2024. Published 18.11.2024. Applicant FNKTsRIO FMBA of Russia (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was performed within the framework of the state assignment of the FMBA of Russia registration number R&D 1022060300090-7-3.2.21.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.11.2025. Accepted for publication: 25.12.2025.